HeraMED's Q3 FY24 achievements

HeraMED Limited (ASX:HMD), a medical data and technology company, has announced notable achievements for Q3 FY24. The company experienced record growth in users on its HeraCARE platform, particularly following its launch at Broward Health in Florida. A 4-point strategic plan is being executed to ensure long-term sustainability. HeraMED has also secured a significant 5-year partnership with INSIGHT Health Research Institute and is planning a partnership with Founda Health to integrate with Electronic Health Records.

HeraMED's strategic outlook

HeraMED continues to advance its mission to transform maternity care through strategic partnerships and platform expansion. The company has grown its HeraCARE user base significantly and is implementing a strategic plan focused on sustainability and innovation. Key partnerships with INSIGHT Health Research Institute and Founda Health aim to enhance product integration and research capabilities. The recent $3.1 million capital raise will support further expansion into major healthcare markets in the US, Europe, and Australia. Looking ahead, HeraMED is committed to strengthening its leadership, enhancing brand visibility, and focusing on commercial strategy and product development.

Executive insights on HeraMED's progress

We are thrilled with the progress made this quarter. Our strategic partnerships and successful capital raise position us well to expand our reach and impact in the maternity care sector. The positive response to HeraCARE at Broward Health is a testament to our commitment to transforming maternity care.